Research and development of increased cell energy potential by streamlining glycolysis processes and oxidative phosphorylation with standardised glycaemic regulation (Q11293): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
(Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement) |
||
Property / financed by | |||
Property / financed by: Directorate-General for Regional and Urban Policy / rank | |||
Revision as of 15:43, 28 October 2020
Project Q11293 in Czech Republic
Language | Label | Description | Also known as |
---|---|---|---|
English | Research and development of increased cell energy potential by streamlining glycolysis processes and oxidative phosphorylation with standardised glycaemic regulation |
Project Q11293 in Czech Republic |
Statements
11,688,887.0 Czech koruna
0 references
16,698,410.0 Czech koruna
0 references
70 percent
0 references
2 January 2018
0 references
31 December 2019
0 references
Euro Enterprise Development s.r.o.
0 references
77900
0 references
Hlavním cílem řešení projektu je realizace průmyslového výzkumu a experimentálního vývoje v konsorciu složeném ze soukromého subjektu (hlavní žadatel) Euro Enterprise Development s. r. o. a veřejného subjektu (ostatní žadatel) Univerzity Palackého v Olomouci, Lékařské fakulty. Konkrétní podporovaný výsledek bude užitný vzor na světově unikátní recepturu, která dokáže zastabilizovat hladinu glukózy v lidském organismu a tak optimalizovat inzulínovou reakci. a. (Czech)
0 references
The main objective of the project is to implement industrial research and experimental development in a consortium consisting of a private entity (main applicant) Euro Enterprise Development s. r. o. and public body (other applicant) of Palacký University Olomouc, Faculty of Medicine. The specific supported result will be a useful pattern in the world’s unique formula, which can stabilise the level of glucose in the human body and thus optimise the insulin response. a. (English)
22 October 2020
0 references
Identifiers
CZ.01.1.02/0.0/0.0/16_084/0010288
0 references